Effect of edema on postimplant dosimetry in prostate brachytherapy using CT/MRI fusion.

Abstract

To investigate the time course of prostatic edema and the effect on the dose-volume histograms of the prostate for patients treated with brachytherapy. A total of 74 patients with prostate cancer were enrolled in this prospective study. A transrectal ultrasound-based preplan was performed 4 weeks before implantation and computed tomography/magnetic resonance imaging fusion-based postimplant dosimetry was performed on the day after implantation (Day 1) and 30 days after implantation (Day 30). The prostate volume, prostate volume covered by 100% of the prescription dose (V100), and dose covering 90% of the prostate (D90) were evaluated with prostatic edema over time. Prostatic edema was greatest on Day 1, with the mean prostate volume 36% greater than the preplan transrectal ultrasound-based volume; it thereafter decreased over time. It was 9% greater than preplan volume on Day 30. The V(100) increased 5.7% from Day 1 to Day 30, and the D90 increased 13.1% from Day 1 to Day 30. The edema ratio (postplan/preplan) on Day 1 of low-quality implants with a V(100) of <80% was significantly greater than that of intermediate- to high-quality implants (>80% V100; p = 0.0272). The lower V100 on Day 1 showed a greater increase from Day 1 to Day 30. A V100 on Day 1 of >92% is unlikely to increase >0% during the interval studied. Low-quality implants on Day 1 were highly associated with edema; however, such a low-quality implant on Day 1, with significant edema, tended to improve by Day 30. If a high-quality implant (V100 >92%) can be obtained on Day 1, a re-examination is no longer necessary.